Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03333746
Title Lenalidomide and Nivolumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Yvonne Efebera
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.